-
Diagnostics World | Until recently, all the available therapeutic options for treating Alzheimer’s disease were designed to reduce symptoms rather than address causes of the disease. But with two beta-amyloid antibodies now approved by the U.S. Food and Drug Administration, and tau-targeting agents in clinical trials, hopes are rising that Alzheimer’s progression can be delayed if not stopped.
Jun 12, 2024
-
Diagnostics World | Sarcoidosis is difficult to diagnose for a variety of reasons. For one, it is not limited to a single area or part of the body. Although the vast majority of people living with sarcoidosis have it in their lungs, it can also appear in the eyes, the skin, brain, heart, spinal cord, liver, kidney, and even in the bones.
Jun 11, 2024
-
Diagnostics World | A potentially game-changing diagnostic assay is under development that can quickly and accurately identify who is and isn’t having a large vessel occlusion (LVO), a devastating subset of ischemic stroke that occurs when a major artery in the brain is blocked.
Jun 6, 2024
-
Diagnostics World News | Late today, Illumina announced that its Board of Directors has approved the spin-off of GRAIL. GRAIL is anticipated to spin off from Illumina on June 24, 2024, and has applied to list on Nasdaq as "GRAL."
Jun 3, 2024
-
Diagnostics World | After decades of false starts, digital pathology adoption is finally happening. Pathologists in these labs don’t have glass slides anywhere in their offices and have completely adapted their workflow and mindset to a digital world. They experience ‘faster than glass’ workflow advantages and tangible benefits associated with AI tools, but also have learned important lessons along the path to adoption.
May 31, 2024
-
Diagnostics World | Quest Diagnostics and PathAI announced a multi-faceted collaboration designed to accelerate the adoption of digital and AI pathology innovations; Ambry Genetics and PacBio were selected to support the Pediatric Mendelian Genomics Research Center (MGRC) program; Foundation Medicine launches FoundationOne RNA; more.
May 29, 2024